info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Disorders of pyruvate metabolism and gluconeogenesis

E4_PYRUGLUNEO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 E74.4
  • Cause of death: ICD-10 E74.4

2 out of 7 registries used, show all original rules.

6

4. Check minimum number of events

None

6

5. Include endpoints

None

6

6. Filter based on genotype QC (FinnGen only)

6

Control definitions (FinnGen only)

Control exclude
E4_METABOLIA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E74
Name in latin
Perturbationes metabolismi pyruvati

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 62 34 28
Only index persons 34 19 15
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 9.42 7.92
Only index persons 12.96 13.34 12.49

-FinnGen-

Key figures

All Female Male
Number of individuals 6 - -
Unadjusted period prevalence (%) 0.00 - -
Median age at first event (years) 19.89 - -

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013650) Neutrophils [#/volume] in Blood by Automated count
6
36
+∞
1.10
42.0
5.0
e9/l
3.6
4.0
—
6
29
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
0
16
0.00
0.49
0.0
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
14
0.00
0.48
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
0
14
0.00
0.48
0.0
1.8
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
6
49
+∞
0.24
44.8
6.7
umol/l
52.8
53.9
—
6
49
(3003338) MCHC [Mass/volume]
6
49
+∞
0.24
65.2
12.4
g/l
339.7
334.9
—
6
49
(3002385) Erythrocyte distribution width [Ratio]
6
49
+∞
0.24
66.5
11.2
%
13.8
13.1
—
6
49
(40761511) CBC panel - Blood by Automated count
6
49
+∞
0.24
13.8
7.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.24
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.23
0.0
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
6
53
+∞
0.00
4.8
3.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
297.7
—
0
7
(3015235) Bicarbonate [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
14.2
—
22.0
—
0
5

Mortality – FinRegistry

Association

Association between endpoint E4_PYRUGLUNEO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_PYRUGLUNEO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: E4_PYRUGLUNEO – Disorders of pyruvate metabolism and gluconeogenesis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data